Bank of Montreal Can grew its holdings in shares of NanoString Technologies, Inc. (NASDAQ:NSTG) by 3,731.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,387 shares of the biotechnology company’s stock after purchasing an additional 9,142 shares during the quarter. Bank of Montreal Can’s holdings in NanoString Technologies were worth $156,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of the business. Goldman Sachs Group Inc. lifted its holdings in shares of NanoString Technologies by 43.1% in the first quarter. Goldman Sachs Group Inc. now owns 71,683 shares of the biotechnology company’s stock worth $1,424,000 after buying an additional 21,584 shares in the last quarter. Platinum Investment Management Ltd. lifted its holdings in shares of NanoString Technologies by 23.8% in the first quarter. Platinum Investment Management Ltd. now owns 92,000 shares of the biotechnology company’s stock worth $1,828,000 after buying an additional 17,700 shares in the last quarter. Credit Suisse AG lifted its holdings in shares of NanoString Technologies by 66.0% in the first quarter. Credit Suisse AG now owns 133,841 shares of the biotechnology company’s stock worth $2,660,000 after buying an additional 53,205 shares in the last quarter. Endurant Capital Management LP purchased a new stake in shares of NanoString Technologies in the first quarter worth about $1,755,000. Finally, Bank of America Corp DE raised its stake in NanoString Technologies by 16.6% in the first quarter. Bank of America Corp DE now owns 11,404 shares of the biotechnology company’s stock valued at $227,000 after purchasing an additional 1,627 shares in the last quarter. Hedge funds and other institutional investors own 92.98% of the company’s stock.
NSTG has been the topic of a number of recent analyst reports. Cowen and Company reaffirmed a “buy” rating on shares of NanoString Technologies in a research note on Friday, July 14th. Zacks Investment Research raised shares of NanoString Technologies from a “hold” rating to a “buy” rating and set a $19.00 target price on the stock in a research note on Wednesday, July 5th. ValuEngine raised shares of NanoString Technologies from a “sell” rating to a “hold” rating in a research note on Friday, June 2nd. Finally, BidaskClub downgraded shares of NanoString Technologies from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $18.50.
NanoString Technologies, Inc. (NASDAQ:NSTG) opened at 15.64 on Friday. NanoString Technologies, Inc. has a one year low of $13.17 and a one year high of $23.45. The company’s market cap is $394.19 million. The stock has a 50 day moving average of $15.03 and a 200 day moving average of $16.94.
NanoString Technologies (NASDAQ:NSTG) last issued its quarterly earnings data on Tuesday, August 8th. The biotechnology company reported ($0.20) EPS for the quarter, beating the consensus estimate of ($0.37) by $0.17. NanoString Technologies had a negative return on equity of 329.59% and a negative net margin of 44.28%. The company had revenue of $34.59 million for the quarter, compared to analyst estimates of $29.87 million. On average, analysts anticipate that NanoString Technologies, Inc. will post ($2.12) earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This article was reported by BBNS and is the sole property of of BBNS. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://baseballnewssource.com/markets/nanostring-technologies-inc-nstg-holdings-boosted-by-bank-of-montreal-can/1604317.html.
About NanoString Technologies
NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.
Receive News & Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related companies with our FREE daily email newsletter.